NIH issues "points to consider" in gene therapy protocols
IRB 1985 March-April; 7(2): 11
Showing items related by title, author, creator and subject.
Recombinant DNA Research; Request for Public Comment on `Points to Consider in the Design and Submission of Human Somatic-Cell Gene Therapy Protocols' United States. Department of Health and Human Services. National Institutes of Health (1985-01-22)
National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee (1985-12)